Skip to content
★ Sign in to follow
AJ

Andrew J. Greenfield

Vice-Président, Directeur Commercial
Total declarations
180
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (69 ops.)
€30.6M

Latest filing published 27 Dec 2022 for ABIOMED INC.

Filing timeline

BuySale
Andrew J. Greenfield

Insider track record

Disclosed buys
0
Disclosed sells
69
Signal history

Andrew J. Greenfield: trading record in brief

This profile gathers the share dealings of Andrew J. Greenfield in Abiomed Inc, where the filings describe the role as senior executive. In total, 180 filings cover trades dated from 30 September 2006 to 22 December 2022.

No open-market purchase appears, only 69 sales worth €30.6M. The rest of the record consists of 74 share grants and 27 option exercises.

The record was last updated on 27 December 2022 with a transaction in Abiomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Andrew J. Greenfield

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations179 total
  • ●
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    0SEC
    23,484 shares0Common Stock, $.01 par valueSEC:0001415889-22-013015:0
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    0SEC
    14 shares0Common Stock, $.01 par valueSEC:0001415889-22-012843:0
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    578,937 USD18SEC
    1,548 shares@ US$373.9974.6% of flowCommon Stock, $.01 par valueSEC:0001415889-22-011183:0
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    0SEC
    34 shares0Common Stock, $.01 par valueSEC:0001415889-22-010224:0
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    254,088 USD11SEC
    954 shares@ US$266.340.8% of flowCommon Stock, $.01 par valueSEC:0001415889-22-005928:2
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    97,480 USD11SEC
    366 shares@ US$266.340.3% of flowCommon Stock, $.01 par valueSEC:0001415889-22-005928:3
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    0SEC
    2,150 shares0Common Stock, $.01 par valueSEC:0001415889-22-005928:1
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    0SEC
    5,348 shares0Common Stock, $.01 par valueSEC:0001415889-22-005928:0
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    75,255 USD12SEC
    302 shares@ US$249.198.9% of flowCommon Stock, $.01 par valueSEC:0001415889-22-005795:0
  • ◆
    VP, CHIEF COMMERCIAL OFFICERExecutivesAbiomed Inc
    0SEC
    25 shares0Common Stock, $.01 par valueSEC:0001415889-22-003744:0
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    541,778 USD11SEC
    1,549 shares@ US$349.761.6% of flowCommon Stock, $.01 par valueSEC:0001179110-21-009904:1
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    0SEC
    6,975 shares0Common Stock, $.01 par valueSEC:0001179110-21-009904:0
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    0SEC
    26 shares0Common Stock, $.01 par valueSEC:0001179110-21-009163:0
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    104,156 USD12SEC
    366 shares@ US$284.5810.7% of flowCommon Stock, $.01 par valueSEC:0001179110-21-006231:0
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    0SEC
    2,000 shares0Common Stock, $.01 par valueSEC:0001179110-21-006011:0
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    165,970 USD11SEC
    618 shares@ US$268.560.5% of flowCommon Stock, $.01 par valueSEC:0001179110-21-005512:1
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    55,860 USD12SEC
    208 shares@ US$268.565.8% of flowCommon Stock, $.01 par valueSEC:0001179110-21-005512:0
  • ◆
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    0SEC
    30 shares0Common Stock, $.01 par valueSEC:0001179110-21-004097:0
  • ◇
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    331,250 USD11SEC
    5,000 shares@ US$66.250.9% of flowCommon Stock, $.01 par valueSEC:0001179110-21-001002:0
  • ▼
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    2M USD12SEC
    5,000 shares@ US$366.005.0% of flowCommon Stock, $.01 par valueSEC:0001179110-21-001002:1
  • ◇
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    107,750 USD11SEC
    5,000 shares@ US$21.550.3% of flowCommon Stock, $.01 par valueSEC:0001179110-21-001001:0
  • ▼
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    2M USD14SEC
    5,000 shares@ US$321.0030.7% of flowCommon Stock, $.01 par valueSEC:0001179110-20-012341:0
  • ▼
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    1M USD14SEC
    4,701 shares@ US$295.5226.6% of flowCommon Stock, $.01 par valueSEC:0001179110-20-012215:0
  • ▼
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    229,040 USD11SEC
    773 shares@ US$296.304.4% of flowCommon Stock, $.01 par valueSEC:0001179110-20-012215:1
  • ▼
    VP, Chief Commercial OfficerExecutivesAbiomed Inc
    297,149 USD12SEC
    1,003 shares@ US$296.265.7% of flowCommon Stock, $.01 par valueSEC:0001179110-20-012215:2

25 of 179 declarations